Subscribe To
U.s. aid shipment of remdesivir arrives in india overnight
The United States sent India 125,000 vials of the anti-viral drug remdesivir Sunday night. Its the four...
November 19, 2022, 9:19 am
An elon musk joke about twitter deal is 2022's top tweet—as court fight looms over it
Musk once seemed jovial about a $44 billion agreement to buy Twitter, but he tweeted Tuesday that he re...
August 10, 2022, 3:34 pm
Ferrovial, s.a. (frrvf) management on q2 2022 results - earnings call transcript
Ferrovial, S.A. (OTCPK:FRRVF) Q2 2022 Earnings Conference Call July 28, 2022 12:00 PM ET Company Partic...
July 30, 2022, 7:40 pm
Adaptimmune: underappreciated biotech with bla filing q4 of 2022
SPEARHEAD-1 trial using afami-cel for the treatment of patients with synovial sarcoma and MRCLS met its...
June 29, 2022, 5:59 am
Ferrovial, s.a. (frrvf) management on q1 2022 results - earnings call transcript
Ferrovial, S.A. (OTCPK:FRRVF) Q1 2022 Earnings Conference Call May 5, 2022 12:00 PM ET Company Particip...
May 8, 2022, 9:22 am
Healthy dividends: organic growth points north for west pharmaceutical services
West Pharmaceutical Services is becoming a vital component of the healthcare industry. West has provided critical products and services required for C...
April 26, 2022, 11:09 pm
Amazon union could face a tough road ahead after victory
In the aftermath of their hard-won labor victory, Amazon workers in the New York City borough of Staten Island popped Champagne, cheered their victory...
April 24, 2022, 11:47 am
Who endorses pfizer's antiviral pill paxlovid for high-risk covid patients but says benefits ‘trivial' for low-risk groups
There will be 84 fewer people admitted to hospital for every 1,000 people with Covid-19 treated with Paxlovid, new data suggests....
April 21, 2022, 6:09 pm
Gilead gets a complete response letter from fda about the vial used to store an experimental hiv drug
Shares of Gilead Sciences Inc. GILD, -1.18% were down 1.0% in premarket trading on Tuesday after the company said it received a complete response lett...
March 1, 2022, 9:22 am
Gilead gets a complete response letter from fda about the vial used to store an experimental hiv drug
Shares of Gilead Sciences Inc. GILD, -1.18% were down 1.0% in premarket trading on Tuesday after the company said it received a complete response lett...
March 1, 2022, 9:22 am
Gilead gets a complete response letter from fda about the vial used to store an experimental hiv drug
Shares of Gilead Sciences Inc. GILD, -1.18% were down 1.0% in premarket trading on Tuesday after the company said it received a complete response lett...
March 1, 2022, 9:22 am
Ferrovial, s.a. (frrvf) ceo ignacio madridejos on q4 2021 results - earnings call transcript
Ferrovial, S.A. (FRRVF) CEO Ignacio Madridejos on Q4 2021 Results - Earnings Call Transcript...
February 26, 2022, 4:11 pm
Ferrovial, s.a. (frrvf) ceo ignacio madridejos on q4 2021 results - earnings call transcript
Ferrovial, S.A. (FRRVF) CEO Ignacio Madridejos on Q4 2021 Results - Earnings Call Transcript...
February 26, 2022, 4:11 pm
Ferrovial, s.a. (frrvf) ceo ignacio madridejos on q4 2021 results - earnings call transcript
Ferrovial, S.A. (FRRVF) CEO Ignacio Madridejos on Q4 2021 Results - Earnings Call Transcript...
February 26, 2022, 4:11 pm
Merck's covid pill could be riskier than investors think
Merck‘s announcement that its antiviral molnupiravir had halved hospitalizations in a trial of high-risk Covid-19 patients was met with enthusiasm o...
October 5, 2021, 4:30 am
Merck's covid pill could be riskier than investors think
Merck‘s announcement that its antiviral molnupiravir had halved hospitalizations in a trial of high-risk Covid-19 patients was met with enthusiasm o...
October 5, 2021, 4:30 am
Merck's covid pill could be riskier than investors think
Merck‘s announcement that its antiviral molnupiravir had halved hospitalizations in a trial of high-risk Covid-19 patients was met with enthusiasm o...
October 5, 2021, 4:30 am
Merck's covid pill could be riskier than investors think
Merck‘s announcement that its antiviral molnupiravir had halved hospitalizations in a trial of high-risk Covid-19 patients was met with enthusiasm o...
October 5, 2021, 4:30 am
Merck's covid pill could be riskier than investors think
Merck‘s announcement that its antiviral molnupiravir had halved hospitalizations in a trial of high-risk Covid-19 patients was met with enthusiasm o...
October 5, 2021, 4:30 am
Merck's covid pill could be riskier than investors think
Merck‘s announcement that its antiviral molnupiravir had halved hospitalizations in a trial of high-risk Covid-19 patients was met with enthusiasm o...
October 5, 2021, 4:30 am